Cello Health

Cello Health are a passionate team of global advisers, expert at navigating life science clients to confident critical decisions

Join our team

We are always on the lookout for great people who want to do things on the cutting edge of science and technology

Join us

Teams of experts

We are expert navigators helping guide our clients to more successful outcomes

Our people

With a global perspective

We work with 24 of the top 25 pharmaceutical companies as well as 100s of biotechs globally from our offices in the US and Europe

Our locations

Giving back

We support a variety of causes across our global business

Giving back

We provide multiple perspectives, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices

We recognise that the journey is often as important as the destination. We work like an extension of your team so your overall journey with us feels better

How we work What we do
We provide multiple perspectives, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices

Share our fresh thinking >

How pharmaceutical companies are driving positive social change
How pharmaceutical companies are driving positive social change
Sustainability and corporate social responsibility (CSR) strategies have shown huge success across industries. The benefits include attracting customers (a 2015 Nielsen survey showed 66% people will pay more for sustainable brands, up from 55% in 2014 and 50% in 2013); attracting and retaining employees; reducing business costs by improving process and supply chain efficiency; and distinguishing your company above competition.
Will a new label extension help Merck realize a rare antimicrobial success story, and what does this mean for the fight against AMR?
Will a new label extension help Merck realize a rare antimicrobial success story, and what does this mean for the fight against AMR?
In rare, positive news in the field of antibiotics, Merck recently announced the approval of Zerbaxa to combat two types of pneumonia commonly found in hospitals.
Are digital diagnostics the way forward in the battered field of Alzheimer's?
Are digital diagnostics the way forward in the battered field of Alzheimer's?
Alzheimer's continues to be a major and steadily growing problem for healthcare systems, with an estimated 5 million patients affected by the disease in the US alone.
From Systematic Literature Reviews to Indirect Treatment Comparisons – Where Do We Start and How Do We Succeed?
From Systematic Literature Reviews to Indirect Treatment Comparisons – Where Do We Start and How Do We Succeed?
This article in ISMPPs May newsletter got me thinking about the way we evaluate literature. If we agree that there is a need to redefine the importance and focus of systematic literature reviews, don’t we also need to reevaluate the literature at the top of the evidence pyramid? I agree that not all evidence is created equally, but surely we should be putting a greater emphasis on patients' experience/voice when focussing on payers and regulators as the target audience.

Let’s work together

The journey to scientific and commercial success is often complex and always critical. If you are looking for an expert partner to help steer you to confident solutions, contact us today

Contact us